Human rabies surveillance and control in China, 2005–2012
© Song et al.; licensee BioMed Central Ltd. 2014
Received: 23 December 2013
Accepted: 8 April 2014
Published: 18 April 2014
Rabies reemerged in China during the 1990s with a gradual increase in the number and geographical dispersion of cases. As a consequence, a national surveillance program was introduced in 2005 to investigate the outbreak in terms of vaccination coverage, PEP treatment, and geographical and social composition.
The surveillance program was coordinated at the national level by the Chinese Center for Disease Control (CCDC) with data collected by regional health centres and provincial CCDCs, and from other official sources. Various statistical and multivariate analysis techniques were then used to evaluate the role and significance of implemented policies and strategies related to rabies prevention and control over this period.
From 2005–2012, 19,221 cases were reported across 30 provinces, but these primarily occurred in rural areas of southern and eastern China, and were predominantly associated with farmers, students and preschool children. In particular, detailed analysis of fatalities reported from 2010 to 2011 shows they were associated with very low rates of post exposure treatment compared to the cases with standard PEP. Nevertheless, regulation of post-exposure prophylaxis quality, together with improved management and vaccination of domesticated animals, has improved prevention and control of rabies.
The various control policies implemented by the government has played a key role in reducing rabies incidences in China. However, level of PEP treatment varies according to sex, age, degree and site of exposure, as well as the source of infection. Regulation of PEP quality together with improved management and vaccination of domesticated animals have also helped to improve prevention and control of rabies.
KeywordsRabies Surveillance Prevention and control Policies
The government began recording human rabies cases in China in 1950 although, initially, only the number of cases at the national level was reported. Nevertheless, the data reveals that rabies has been responsible for hundreds to thousands of fatalities in most years since recordkeeping began. Towards the end of the last century, rabies reemerged in China and became the leading cause of fatalities among the 37 notifiable infectious diseases recognized by the Ministry of Health (MOH). As a consequence, a national rabies surveillance program was implemented in 2005 in provinces and cities reporting the highest case rates . The goals of this program included identifying factors driving the epidemic, the populations most at risk and the effectiveness of current control measures. Based on the initial findings, the surveillance program was subsequently expanded to encompass all epidemic regions in the country. At the same time, the national government, together with the health, agriculture, public security and drug supervision sectors, used these findings in the implementation of a number of preliminary control measures. As a consequence, from 2008, the number of fatalities case number began to fall and by 2012 the number of fatalities had dropped by 57% compared to 2007. In this report we perform a detailed examination of the data collected over the past seven years and discuss the progress in prevention and control of rabies in China.
Rabies surveillance in China
To investigate the immunization coverage in domestic dogs and cats, both an ecological survey (collection of population and vaccination data from local agricultural departments) and a household survey (collection of relevant data from local households by CDC staff) were performed at 15 surveillance sites between 2005 and 2011. Data on 19,208,488 dogs and 4,067,754 cats were collected by ecological survey, and 98,392 dogs and 97,697 cats were collected by household survey.
Government policies for rabies prevention and control
The implemented rabies prevention and control policies required cooperation between various ministries and bodies at the national level and in 2003, the MOH, the Ministry of Public Security, the Ministry of Agriculture (MOA) and the State Food and Drug Administration (SFDA) each published reports and recommendations for rabies prevention and control with a view to establishing a consolidated national policy. In particular: (i) the SFDA implemented a program for the batch release of rabies vaccine for better tracking of vaccine production and quality control and revised minimum acceptable standards for quality of manufactured human vaccine in China, (ii) the MOH examined the plausibility of integrating PEP costs into the new rural cooperative medical service to improve PEP treatment in rural areas , (iii) the closer integration of dog management and vaccination efforts by the MOA and Ministry of Public Security.
Various statistical methods were used to investigate the data collected from surveillance program and from other official sources. In particular, significant differences or correlations in the temporal, spatial and population distribution were considered using the chi-squared test. Logistic regression was used to identify relationships between PEP and degree of exposure and other influencing factors. The Pearson chi-square test and Exact test were applied to identify key differences in PEP between population or social factors. We also used the chi-squared test to consider whether the introduction of the rural cooperative medical care program had produced significant changes in the percentage of people seeking PEP after a potential rabies exposure event.
The program for collection of human brain samples was approved by the Ethical Committee of the National Institute of Viral Disease Control and Prevention, China CDC, which is the national referral center for rabies diagnosis. Due to their medical condition, subjects were unable to provide consent once a rabies infection was suspected and so written informed consent was obtained in all cases from their relatives after death.
Epidemiology situation and analysis
Although there have been no fatalities in Tibet, in 2012, one patient was bitten by two dogs and received PEP treatment, and the brain tissue samples of the two dogs revealed the presence of rabies infection. In the same year, suspected rabies cases occurred in a dairy farm in Inner Mongolia in 2 cows that were bitten by dogs that were subsequently confirmed as infected with rabies. Finally, the first case of an imported human fatality occurred in Beijing in an Israeli national who was injured by monkeys in India and manifested the early symptoms of rabies after arriving in Beijing. Clinical diagnosis was confirmed after hospitalization and the patient died one week after the onset of the initial symptoms. The specimens of cerebrospinal fluid and saliva of the Israeli patient were sent to the laboratory of Institute for Viral Disease Control and Prevention of China CDC and tested positive for rabies.
Human rabies cases survey and analysis
PEP overall statistics for rabies deaths and exposed population
Total number of cases
By host (%)
Exposure category (%)
Wound treatment rate (%)
Vaccine inoculation rate (%)
Complete inoculation treatment (5 dose)
Antibody injection rate (%)
Injection rate for category III cases
The results showed that these human rabies cases were primarily a consequence of injures received from dogs (93.7%) and cats (4.6%) (Table 1), with the remainder associated with other domestic animals and wildlife including horses, pigs, rats and squirrels. Exposure occurred in 87.6% of cases through bites and 9.4% by scratches. Six cases were caused by the consumption or processing of dog meat. The degree of injury is classified from category I to category III, with category I the least severe (e.g., animal licking intact skin), to category II (e.g. minor scratch with or without bleeding), and category III the most severe (e.g., puncture wounds or lacerations). 75.9% of reported fatalities were category III exposure. Most of the cases with category III exposure did not receive preventive treatment according to the WHO recommendations for PEP, with few subjects receiving PEP, low rates of wound treatment (9.08%), vaccination (<10%) and immunoglobulin injection (<3%). For the category II cases, only 2 out of 267 cases were vaccinated: one patient was vaccinated on the 16th day post exposure and died on the 20th day. Also, comparison of the cases with category II and III exposures revealed there were significantly more fatalities associated with category III exposure (Pearson chi-square test and exact test, P = 0.0118).
PEP treatment in suspected rabies cases
Rabies deaths and exposed population according to age, population and gender
Location of exposure
Head, face, neck
Details of logistic regression analysis used to determine influential factors associated with rabies fatalities
OR (95% CI)
Overall Model Evaluation: Likelihood Ratio Test, Chi-squared 29.7357, P = 0.0001
Overall Model Evaluation: Likelihood Ratio Test, Chi-squared 146.3388, P < 0.0001
Overall Model Evaluation: Likelihood Ratio Test, Chi-squared 95.9648, P < 0.0001
Analysis of vaccination rates also revealed a number of differences in the composition of cases. Specifically, Pearson chi-squared tests and exact tests revealed that vaccination was more likely to be associated with: 1. cases occurring in children under the age of 15 compared to other groups (P < 0.0001). 2. category III exposure rather than category II cases (P = 0.0116), 3. head and neck wounds over other locations. (P < 0.0001) 4. cases associated with neighbor’s dogs compared to cases associated with family dogs (P = 0.0004), 5. cases associated with roaming dogs more than domesticated dogs (P = 0.0005).
Similarly, immunoglobulin injections were more likely to be associated with 1. cases occurring in children under 15 years old (P < 0.0001) 2. head and neck wounds over other locations (P < 0.0001), 3. cases associated with neighbor’s dogs compared to cases associated with family dogs (P = 0.0052), 4. cases associated with roaming dogs more than domesticated dogs (P = 0.0020).
Injury statistics by region and host as reported from PEP clinics from 2005 to 2011
Number of cases
Injury by dog (%)*
Injury by cat (%)*
Surveillance of animal host for human rabies
There have also been reports of rabies cases in wildlife and subsequent human cases as a consequence of exposure to infected animals. These reports originated in Zhejiang, Anhui and Jiangxi provinces and case numbers have increased in recent years, especially human rabies cases caused by ferret badgers [4–7].
Laboratory testing of collected isolates
Rabies prevention and control since surveillance
As discussed above, analysis of human case data showed that lack of PEP or use of non-standard PEPs is a key factor in determining the outcome of human rabies cases. The primary reasons for failing to obtain PEP is due to limited awareness of rabies and poverty levels in rural areas .
Summarization of coverage and expenditure of the new rural cooperative medical (NRCM) program in China from 2005 to 2011
Number of regions incorporating NRCM program
Number of people enrolled in NRCM (×107)
Percentage of target population enrolled in NRCM (%)
Financing per person (Yuan)
Total expenditure per year (hundred million Yuan)
Compensation benefits/106 persons/year
Another important development is the observed improvement of quality and consistency of rabies vaccines manufactured in China from 2005 to 2012. In the previous major epidemic that occurred in the 1980s, only the Essen regimen was available. Since then, cell culture rabies vaccines have replaced the nerve tissue rabies vaccines, and the Zagreb regimen was approved and introduced in China in 2010. All the human rabies vaccines produced in China are purified cell culture vaccine without adjuvant. In 2010, the SFDA (State Food and Drug Administration) of China revised the China pharmacopoeia, providing officials standards (such as purity, dosage, precautions and storage) for recognized drugs, and further improved the human rabies vaccine quality requirements . As a consequence of these efforts, China is now one of the largest producers and consumers of human rabies vaccine. Thus, more choices are now available for rabies vaccine administration.
The rabies surveillance program is now well established in China, and provides a comprehensive overview of the rabies situation throughout the country. At the same time, it is possible to use the data to review the situation within a specific region at the provincial, county or even within a specific group of villages. With this information it is possible to identify hotspots that may be associated with a local outbreak and provide the necessary control measures to prevent further spread.
Analysis of the collected data allowed the identification of rabies hotspots so they could be prioritized for control measures. Furthermore, statistical analysis revealed a number of trends that were facilitating the spread of the virus as well as increasing fatality rates. Based on these findings the government was able to implement strategies that could effectively curb further increases in fatality rates. One key factor was the identification of “at risk” populations, raising their awareness of the disease, informing them of risks from infectious animals as well as how to recognize the symptoms, and the importance of seeking PEP treatment in the event of potential exposure. Secondly, the introduction of the new rural cooperative medical subsidies for PEP costs made it easier for people in low income areas to seek treatment. Finally, introductory efforts for dog management and free immunization in high-incidence areas have highlighted the effectiveness of this approach for controlling the spread of rabies.
Although the annual number of rabies cases in China has been decreasing since 2008, this has been achieved by controlling cases in high and medium incidence provinces. The surveillance data from reported cases reveals that rabies is gradually expanding from the southern and eastern regions to the northern and western regions of China. Although the rapid economic development in China has made it possible to implement a surveillance program and fund PEP costs, it is the changes in lifestyle that are a consequence of this development that have helped to create an environment to facilitate the spread of rabies. As personal wealth has increased, so has dog ownership , where they generally serve as pets in cities or as guard dogs in the countryside. Furthermore, the ownership of private vehicles has also grown together with an efficient transportation infrastructure. Thus, the host population primarily responsible for human cases has not only grown rapidly, but has also become more mobile.
The question of how to manage and immunize the rapidly-increasing domestic dogs population has developed into an important social issue. Furthermore, efforts in the last decade to restore the natural environment in China has promulgated a series of laws and regulations, such as the “Wildlife Conservation Law” and the “Regulation on Terrestrial Wildlife Protection” act which has established more than 2000 nature reserves as major habitats for wild animals. Additionally, projects such as the natural forest protection project and the Grain for Green Project has prohibited hunting in these areas protecting these wildlife species . Thus, while these efforts have helped to restore these natural environments, it has facilitated the rapid recovery of wildlife populations in these areas, which serve as effective reservoirs for rabies. This is supported by the increase in reported rabies cases in wildlife in these regions .
The situation in China contrasts with that found in North America  and Europe . In these regions, an effective vaccination program has eliminated the virus in domestic animals and a comprehensive oral vaccine bait effort has helped to significantly control the disease in wildlife. However, repeated reports of outbreaks in local wildlife populations, raccoons in particular, e.g., [20, 21] highlights the continued threat from this pathogen.
Despite the importance of PEP treatment following potential exposure to rabies, in many fatal cases patients failed to obtain this treatment. Our analysis indicates that there are two reasons for this. Firstly, in the mid-1990s, rabies had been effectively brought under control in China, with only low-incidence or scattered cases and, as public awareness of the disease fell, there was little effort directed to rabies prevention and control. Even after an attack by a dog, people rarely sought medical treatment. Secondly, even after the number of cases began to increase again and people became more aware of the importance of proper treatment, the costs were prohibitively high in many low income areas. Additionally, many health departments or clinics in villages lacked the facilities for providing PEP or had a shortage of rabies vaccine. Hence, efforts to improve awareness in the population in high incident regions as well as subsidization for PEP treatment together with education of the medical personnel for storage and delivery of PEP treatment according to WHO recommendations were key to reducing rabies cases in these regions.
Continued efforts are needed to further control rabies and to prevent its reemergence in new areas. This is remains a priority with the State Council and the relevant state departments such as the Ministries of Health, Public Security and Agriculture . The State Council outlined their future plan in the document Long-term Animal Disease Prevention and Control Plan (2012–2020), which lists the rabies as one of 16 domesticated animal diseases to be prioritized for prevented and controlled. This plan will be implemented in part via agricultural sectors and public security departments, and includes introduction of a pilot program for identifying dogs that have been immunized and by introducing further training courses on animal rabies prevention and diagnosis for the professionals in veterinary departments . All these policies and efforts will be important factors for further control of rabies in China.
The national surveillance program has proved valuable for understanding the causes of the current rabies epidemic in China, as well as determining the effectiveness of the various control policies. In particular, the availability of PEP treatment is key to reducing fatalities. The results from this study should also be useful to other countries or regions facing similar challenges from rabies outbreaks.
Miao Song is an Assistant Professor at Liupanshui Vocational and Technical College in Guizhou province. She completed her Masters degree within the State Key Laboratory for Infectious Disease Prevention and Control at the Chinese Center for Disease Control in Beijing: Her research focused on the investigation of factors contributing to the spread of rabies in China, and this remains the focus of her current research interests.
This work was supported by the funding from the National Department Public Benefit Research Foundation (201103032) and the National Basic Research Program of China (2012CB721100).
- Rabies Monitoring Program in China (Tentative Version). 2005, : Ministry of Health, 09-08
- Circular on Including Rabies Vaccination Expenses within Compensation Scope of New Rural Cooperative Medical Service. 2009, : Department of Health of Guangdong Province, 11-05
- Song M, Tang Q, Wang DM, Mo ZJ, Guo SH, Li H, Tao XY, Rupprecht CE, Feng ZJ, Liang GD: Epidemiological investigations of human rabies in China. BMC Infect Dis. 2009, 9: 210-10.1186/1471-2334-9-210.PubMed CentralView ArticlePubMed
- Zhang S, Tang Q, Wu X, Liu Y, Zhang F, Rupprecht CE, Hu R: Rabies in ferret badgers, southeastern China. Emerg Infect Dis. 2009, 15 (6): 946-949. 10.3201/eid1506.081485.PubMed CentralView ArticlePubMed
- Wang L, Wu H, Tao X, Li H, Rayner S, Liang G, Tang Q: Genetic and evolutionary characterization of RABVs from China using the phosphoprotein gene. Virol J. 2013, 10: 14-10.1186/1743-422X-10-14.PubMed CentralView ArticlePubMed
- Sun J, Xu B: Influence factor and characteristics of human rabies during incubation period. Chin J Zoonoses. 2011, 27 (2): 154-157.
- Hu J, Xu T, Wu Z, Shi Y, Zhao L, Shen X, Liu M: A study on the epidemiological characteristics and the preventive measures of rabies in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi. 2001, 22 (1): 11-13.PubMed
- Tao XY, Tang Q, Li H, Mo ZJ, Zhang H, Wang DM, Zhang Q, Song M, Velasco-Villa A, Wu X, Rupprecht CE, Liang GD: Molecular epidemiology of rabies in Southern People’s Republic of China. Emerg Infect Dis. 2009, 15 (8): 1192-1198. 10.3201/eid1508.081551.PubMed CentralView ArticlePubMed
- Yu J, Li H, Tang Q, Rayner S, Han N, Guo Z, Liu H, Adams J, Fang W, Tao X, Wang S, Liang GD: The spatial and temporal dynamics of rabies in China. PLoS Negl Trop Dis. 2012, 6 (5): e1640-10.1371/journal.pntd.0001640.PubMed CentralView ArticlePubMed
- Guo Z, Tao X, Yin C, Han N, Yu J, Li H, Liu H, Fang W, Adams J, Wang J, Liang G, Tang Q, Rayner S: National borders effectively halt the spread of rabies: the current rabies epidemic in china is dislocated from cases in neighboring countries. PLoS Negl Trop Dis. 2013, 7 (1): e2039-10.1371/journal.pntd.0002039.PubMed CentralView ArticlePubMed
- Tao XY, Tang Q, Rayner S, Guo ZY, Li H, Lang SL, Yin CP, Han N, Fang W, Adams J, Song M, Liang GD: Molecular phylodynamic analysis indicates lineage displacement occurred in Chinese rabies epidemics between 1949 to 2010. PLoS Negl Trop Dis. 2013, 7 (7): e2294-10.1371/journal.pntd.0002294.PubMed CentralView ArticlePubMed
- Hu R, Tang Q, Tang J, Fooks AR: Rabies in China: an update. Vector Borne Zoonotic Dis. 2009, 9 (1): 1-12. 10.1089/vbz.2008.0046.View ArticlePubMed
- Jiao W, Li H, Tao X, Song M, Shen X, Guo Z, Zhao Y, Tang Q, Liang G: Investigation and analysis of rabies viral infection and distribution in China in 2005–2012. Virol Sin. 2013, 28 (3): 183-185. 10.1007/s12250-013-3324-7.View ArticlePubMed
- Yin CP, Zhou H, Wu H, Tao XY, Rayner S, Wang SM, Tang Q, Liang GD: Analysis on factors related to rabies epidemic in China from 2007–2011. Virol Sin. 2012, 27 (2): 132-143. 10.1007/s12250-012-3244-y.View ArticlePubMed
- Pharmacopoeia of People’s Republic of China. Part 3. 2010, Beijing: Chinese Medical Science and Technology Press: National Pharmacopoeia Committee
- Zhang J, Jin Z, Sun GQ, Zhou T, Ruan S: Analysis of rabies in China: transmission dynamics and control. PLoS One. 2011, 6 (7): e20891-10.1371/journal.pone.0020891.PubMed CentralView ArticlePubMed
- Zhang Z, Huang S, Deng X, Yang D: Analysis of the factors related to rabies epidemic in Guilin from 2003 to 2006. Mod Prev Med. 2008, 35 (14): 2768-2770.
- Slate D, Algeo TP, Nelson KM, Chipman RB, Donovan D, Blanton JD, Niezgoda M, Rupprecht CE: Oral rabies vaccination in north america: opportunities, complexities, and challenges. PLoS Negl Trop Dis. 2009, 3 (12): e549-10.1371/journal.pntd.0000549.PubMed CentralView ArticlePubMed
- Freuling CM, Hampson K, Selhorst T, Schroder R, Meslin FX, Mettenleiter TC, Muller T: The elimination of fox rabies from Europe: determinants of success and lessons for the future. Philos Trans R Soc Lond B Biol Sci. 2013, 368 (1623): 20120142-10.1098/rstb.2012.0142.PubMed CentralView ArticlePubMed
- Talbot B, Garant D, Rioux Paquette S, Mainguy J, Pelletier F: Lack of genetic structure and female-specific effect of dispersal barriers in a rabies vector, the striped skunk (Mephitis mephitis). PLoS One. 2012, 7 (11): e49736-10.1371/journal.pone.0049736.PubMed CentralView ArticlePubMed
- Slavinski S, Humberg L, Lowney M, Simon R, Calvanese N, Bregman B, Kass D, Oleszko W: Trap-vaccinate-release program to control raccoon rabies, New York, USA. Emerg Infect Dis. 2012, 18 (7): 1170-1172. 10.3201/eid1807.111485.PubMed CentralView ArticlePubMed
- Notice on Issuance of Rabies Prevention and Control Situation in China. 2009, : Ministry of health, Ministry of public security, Ministry of Agriculture, State Food and drug administration, 09-22
- Notice on Rabies Prevention and Control Work. 2003, : Ministry of health, Ministry of public security, Ministry of Agriculture, State Food and drug administration, 12-21
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/14/212/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.